Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms

Background: The coronavirus disease 2019 (COVID-19) pandemic and lockdown might increase anxiety and depressive symptoms in most individuals. Health bodies recommend several coping behaviors to protect against such symptoms, but evidence on the relationship between these behaviors and symptoms mostl...

Full description

Bibliographic Details
Main Authors: Lydia Fortea, Aleix Solanes, Edith Pomarol-Clotet, Maria Angeles Garcia-Leon, Adriana Fortea, Carla Torrent, Cristina Varo, C. Mar Bonnin, Laura Montejo, Jordi Alonso, Susana Carmona, Pau Soldevila-Matías, Irene Alustiza, Daniel Arbós, Diego Hidalgo-Mazzei, Iria Grande, Eduard Vieta, Miquel Àngel Fullana, Joaquim Radua
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.642763/full
_version_ 1818865066538172416
author Lydia Fortea
Lydia Fortea
Lydia Fortea
Aleix Solanes
Aleix Solanes
Edith Pomarol-Clotet
Edith Pomarol-Clotet
Maria Angeles Garcia-Leon
Adriana Fortea
Adriana Fortea
Carla Torrent
Carla Torrent
Carla Torrent
Cristina Varo
Cristina Varo
Cristina Varo
Cristina Varo
C. Mar Bonnin
C. Mar Bonnin
C. Mar Bonnin
C. Mar Bonnin
Laura Montejo
Laura Montejo
Laura Montejo
Laura Montejo
Jordi Alonso
Jordi Alonso
Jordi Alonso
Susana Carmona
Susana Carmona
Susana Carmona
Pau Soldevila-Matías
Irene Alustiza
Irene Alustiza
Daniel Arbós
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Iria Grande
Iria Grande
Iria Grande
Iria Grande
Eduard Vieta
Eduard Vieta
Eduard Vieta
Eduard Vieta
Miquel Àngel Fullana
Miquel Àngel Fullana
Miquel Àngel Fullana
Joaquim Radua
Joaquim Radua
Joaquim Radua
Joaquim Radua
author_facet Lydia Fortea
Lydia Fortea
Lydia Fortea
Aleix Solanes
Aleix Solanes
Edith Pomarol-Clotet
Edith Pomarol-Clotet
Maria Angeles Garcia-Leon
Adriana Fortea
Adriana Fortea
Carla Torrent
Carla Torrent
Carla Torrent
Cristina Varo
Cristina Varo
Cristina Varo
Cristina Varo
C. Mar Bonnin
C. Mar Bonnin
C. Mar Bonnin
C. Mar Bonnin
Laura Montejo
Laura Montejo
Laura Montejo
Laura Montejo
Jordi Alonso
Jordi Alonso
Jordi Alonso
Susana Carmona
Susana Carmona
Susana Carmona
Pau Soldevila-Matías
Irene Alustiza
Irene Alustiza
Daniel Arbós
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Iria Grande
Iria Grande
Iria Grande
Iria Grande
Eduard Vieta
Eduard Vieta
Eduard Vieta
Eduard Vieta
Miquel Àngel Fullana
Miquel Àngel Fullana
Miquel Àngel Fullana
Joaquim Radua
Joaquim Radua
Joaquim Radua
Joaquim Radua
author_sort Lydia Fortea
collection DOAJ
description Background: The coronavirus disease 2019 (COVID-19) pandemic and lockdown might increase anxiety and depressive symptoms in most individuals. Health bodies recommend several coping behaviors to protect against such symptoms, but evidence on the relationship between these behaviors and symptoms mostly comes from cross-sectional studies in convenience samples. We will conduct a prospective longitudinal study of the associations between coping behaviors and subsequent anxiety and depressive symptoms during the COVID-19 pandemic in a representative sample of the Spanish general adult population.Methods: We will recruit 1,000 adult participants from all autonomous communities of Spain and with sex, age, and urbanicity distributions similar to those of their populations and assess anxiety and depressive symptoms and coping behaviors using fortnightly questionnaires and real-time methods (ecological momentary assessments) for 1 year. The fortnightly questionnaires will inquire about anxiety and depressive symptoms [General Anxiety Disorder-7 (GAD-7) and Patient Health Questionnaire-9 (PHQ-9)] and the frequency of 10 potential coping behaviors (e.g., follow a routine) during the past 2 weeks. In addition, we will collect several variables that could confound or moderate these associations. These will include subjective well-being [International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) and Satisfaction with Life Scale (SWLS)], obsessive-compulsive symptoms [Obsessive Compulsive Inventory-Revised (OCI-R)], personality and emotional intelligence [International Personality Item Pool (IPIP) and Trait Emotional Intelligence Questionnaire Short Form (TEIQue-SF)], sociodemographic factors (e.g., work status, housing-built environment), and COVID-19 pandemic-related variables (e.g., hospitalizations or limitations in social gatherings). Finally, to analyze the primary relationship between coping behaviors and subsequent anxiety and depressive symptoms, we will use autoregressive moving average (ARMA) models.Discussion: Based on the study results, we will develop evidence-based, clear, and specific recommendations on coping behaviors during the COVID-19 pandemic and lockdown. Such suggestions might eventually help health bodies or individuals to manage current or future pandemics.
first_indexed 2024-12-19T10:41:38Z
format Article
id doaj.art-73f1b13f9443456d9a42047363163a57
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-19T10:41:38Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-73f1b13f9443456d9a42047363163a572022-12-21T20:25:25ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-07-011210.3389/fpsyt.2021.642763642763Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive SymptomsLydia Fortea0Lydia Fortea1Lydia Fortea2Aleix Solanes3Aleix Solanes4Edith Pomarol-Clotet5Edith Pomarol-Clotet6Maria Angeles Garcia-Leon7Adriana Fortea8Adriana Fortea9Carla Torrent10Carla Torrent11Carla Torrent12Cristina Varo13Cristina Varo14Cristina Varo15Cristina Varo16C. Mar Bonnin17C. Mar Bonnin18C. Mar Bonnin19C. Mar Bonnin20Laura Montejo21Laura Montejo22Laura Montejo23Laura Montejo24Jordi Alonso25Jordi Alonso26Jordi Alonso27Susana Carmona28Susana Carmona29Susana Carmona30Pau Soldevila-Matías31Irene Alustiza32Irene Alustiza33Daniel Arbós34Diego Hidalgo-Mazzei35Diego Hidalgo-Mazzei36Diego Hidalgo-Mazzei37Diego Hidalgo-Mazzei38Iria Grande39Iria Grande40Iria Grande41Iria Grande42Eduard Vieta43Eduard Vieta44Eduard Vieta45Eduard Vieta46Miquel Àngel Fullana47Miquel Àngel Fullana48Miquel Àngel Fullana49Joaquim Radua50Joaquim Radua51Joaquim Radua52Joaquim Radua53Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainImaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainFIDMAG Research Foundation, Barcelona, SpainFIDMAG Research Foundation, Barcelona, SpainMultimodal Neuroimaging in High Risk and Early Psychosis, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainDepartment of Child and Adolescent Psychiatry, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain0Health Services Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain1Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain3Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain4Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Getafe, Spain5Department of Basic Psychology, Faculty of Psychology, University of Valencia, Valencia, Spain6Department of Psychiatry and Clinical Psychology, Clínica Universidad de Navarra, Pamplona, Spain7Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain8Communication Office, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainDepartment of Medicine, University of Barcelona, Barcelona, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainBipolar and Depressive Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainImaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, SpainAdult Psychiatry and Psychology Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, SpainImaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain9Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom0Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, SwedenBackground: The coronavirus disease 2019 (COVID-19) pandemic and lockdown might increase anxiety and depressive symptoms in most individuals. Health bodies recommend several coping behaviors to protect against such symptoms, but evidence on the relationship between these behaviors and symptoms mostly comes from cross-sectional studies in convenience samples. We will conduct a prospective longitudinal study of the associations between coping behaviors and subsequent anxiety and depressive symptoms during the COVID-19 pandemic in a representative sample of the Spanish general adult population.Methods: We will recruit 1,000 adult participants from all autonomous communities of Spain and with sex, age, and urbanicity distributions similar to those of their populations and assess anxiety and depressive symptoms and coping behaviors using fortnightly questionnaires and real-time methods (ecological momentary assessments) for 1 year. The fortnightly questionnaires will inquire about anxiety and depressive symptoms [General Anxiety Disorder-7 (GAD-7) and Patient Health Questionnaire-9 (PHQ-9)] and the frequency of 10 potential coping behaviors (e.g., follow a routine) during the past 2 weeks. In addition, we will collect several variables that could confound or moderate these associations. These will include subjective well-being [International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) and Satisfaction with Life Scale (SWLS)], obsessive-compulsive symptoms [Obsessive Compulsive Inventory-Revised (OCI-R)], personality and emotional intelligence [International Personality Item Pool (IPIP) and Trait Emotional Intelligence Questionnaire Short Form (TEIQue-SF)], sociodemographic factors (e.g., work status, housing-built environment), and COVID-19 pandemic-related variables (e.g., hospitalizations or limitations in social gatherings). Finally, to analyze the primary relationship between coping behaviors and subsequent anxiety and depressive symptoms, we will use autoregressive moving average (ARMA) models.Discussion: Based on the study results, we will develop evidence-based, clear, and specific recommendations on coping behaviors during the COVID-19 pandemic and lockdown. Such suggestions might eventually help health bodies or individuals to manage current or future pandemics.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.642763/fullCOVID-19anxietydepressive symptomscoping behaviorslongitudinal study
spellingShingle Lydia Fortea
Lydia Fortea
Lydia Fortea
Aleix Solanes
Aleix Solanes
Edith Pomarol-Clotet
Edith Pomarol-Clotet
Maria Angeles Garcia-Leon
Adriana Fortea
Adriana Fortea
Carla Torrent
Carla Torrent
Carla Torrent
Cristina Varo
Cristina Varo
Cristina Varo
Cristina Varo
C. Mar Bonnin
C. Mar Bonnin
C. Mar Bonnin
C. Mar Bonnin
Laura Montejo
Laura Montejo
Laura Montejo
Laura Montejo
Jordi Alonso
Jordi Alonso
Jordi Alonso
Susana Carmona
Susana Carmona
Susana Carmona
Pau Soldevila-Matías
Irene Alustiza
Irene Alustiza
Daniel Arbós
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Iria Grande
Iria Grande
Iria Grande
Iria Grande
Eduard Vieta
Eduard Vieta
Eduard Vieta
Eduard Vieta
Miquel Àngel Fullana
Miquel Àngel Fullana
Miquel Àngel Fullana
Joaquim Radua
Joaquim Radua
Joaquim Radua
Joaquim Radua
Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
Frontiers in Psychiatry
COVID-19
anxiety
depressive symptoms
coping behaviors
longitudinal study
title Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
title_full Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
title_fullStr Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
title_full_unstemmed Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
title_short Study Protocol—Coping With the Pandemics: What Works Best to Reduce Anxiety and Depressive Symptoms
title_sort study protocol coping with the pandemics what works best to reduce anxiety and depressive symptoms
topic COVID-19
anxiety
depressive symptoms
coping behaviors
longitudinal study
url https://www.frontiersin.org/articles/10.3389/fpsyt.2021.642763/full
work_keys_str_mv AT lydiafortea studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT lydiafortea studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT lydiafortea studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT aleixsolanes studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT aleixsolanes studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT edithpomarolclotet studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT edithpomarolclotet studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT mariaangelesgarcialeon studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT adrianafortea studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT adrianafortea studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT carlatorrent studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT carlatorrent studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT carlatorrent studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cristinavaro studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cristinavaro studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cristinavaro studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cristinavaro studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cmarbonnin studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cmarbonnin studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cmarbonnin studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT cmarbonnin studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT lauramontejo studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT lauramontejo studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT lauramontejo studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT lauramontejo studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT jordialonso studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT jordialonso studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT jordialonso studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT susanacarmona studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT susanacarmona studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT susanacarmona studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT pausoldevilamatias studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT irenealustiza studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT irenealustiza studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT danielarbos studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT diegohidalgomazzei studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT diegohidalgomazzei studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT diegohidalgomazzei studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT diegohidalgomazzei studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT iriagrande studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT iriagrande studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT iriagrande studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT iriagrande studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT eduardvieta studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT eduardvieta studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT eduardvieta studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT eduardvieta studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT miquelangelfullana studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT miquelangelfullana studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT miquelangelfullana studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT joaquimradua studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT joaquimradua studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT joaquimradua studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms
AT joaquimradua studyprotocolcopingwiththepandemicswhatworksbesttoreduceanxietyanddepressivesymptoms